Our Solutions   Bortero 2 mg Injection

Bortero 2 mg Injection

Bortero 2Mg Injection

*To be consumed as directed by physician.

Therapies:

Anti Neoplastics

Composition:

Bortezomib (2 mg)

About Bortero 2Mg Injection

Bortero 2 mg Injection is an anti-cancer medication used to treat adult patients with multiple myeloma and mantle cell lymphoma who have undergone at least one prior therapy.

Multiple myeloma: Also known as myeloma, is a type of bone marrow cancer that affects various areas of the body, including the spine, skull, pelvis, and ribs.

Mantle cell lymphoma (MCL): A rare type of non-Hodgkin lymphoma (NHL) that develops when B-cells (B-lymphocytes), which are white blood cells that fight infection, become abnormal.

Bortero 2 mg Injection contains 'Bortezomib,' which works by interfering with proteasomes, leading to the death of cancer cells and preventing cancer growth.

Bortero 2Mg Injection

*To be consumed as directed by physician.


Usage Instructions

Administration:
  • Bortero 2 mg Injection is prescribed by a doctor experienced in cancer treatment.
  • It is administered by a healthcare professional, either intravenously (IV) or subcutaneously (SC).

Benefits and Use

Bortezomib is used in the treatment of multiple myeloma and mantle-cell lymphoma.


Safety Information

  • Use an effective method of birth control to avoid pregnancy while taking this medication.
  • You may need to have blood tests to monitor your blood cells, platelets count, liver function and kidney function during treatment.
  • Inform your doctor immediately if you experience coughing, shortness of breath and swelling of feet.

Ingredients

Bortezomib (2 mg)

How to Use

  • Do not skip any dose and complete the course as suggested by your doctor.

Storage Information

Store unopened vials in the refrigerator (2 °C – 8 °C) and protect them from light. Keep this medicine out of sight and reach of children.